As the field of interventional cardiology continues to evolve, innovations in imaging and stent-free treatment methods are ...

The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The ...

Stent-grafts are emerging as the preferred minimally invasive ... a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination ...

there have been numerous advances in minimally invasive surgery and in medical and percutaneous treatments for coronary artery disease. This 2004 revision reflects those advances and presents ...

Additionally, they share the same sophisticated catheter delivery method and stent design. To improve the management of ...

He has a history of a recent myocardial infarction (MI) that was treated with a stent 3 weeks ... and has known coronary ...

Medically reviewed by Christopher Lee, MD Coronary artery disease (CAD) occurs when there's a blockage in the arteries that carry blood and oxygen to the heart muscle. CAD is the most common type of ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

On World Heart Day, Dr. Praveen Chandra highlights the dangers of cardiovascular diseases beyond heart attacks.

The "Plaque Modification Devices - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The plaque modification devices market was valued ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...